The Fondation Leducq is a non-profit organization which supports research in cardiovascular disease. The intellectual property policy of the foundation, which forms a part of the foundation’s research agreement, is based on two principles. First, it is in the public interest and in the interest of the foundation that any intellectual property arising in connection with research supported by Fondation Leducq grants be developed, particularly by persons or institutions having adequate resources and incentives to do so. Second, the foundation is interested in ensuring that some of the income resulting from the commercialization of such intellectual property be directed back towards cardiovascular and neurovascular research in the form of grants.
The intellectual property policy below is taken from the research agreement which is signed by the Fondation Leducq and the research centers under the Transatlantic Networks of Excellence program. This agreement pertains in cases where researchers assign intellectual property to the institution at which the research was conducted. A variation of this agreement pertains in the case of researchers working for the Howard Hughes Medical Institute (see the * in the IP agreement). Two other special cases obtain: (1) Because of the particular tax consequences for researchers at French institutions resulting from an intellectual property agreement, the Fondation Leducq has developed a special agreement with INSERM and other French research centers; (2) In the event that an individual retains control over the intellectual property that he or she develops, and is not obligated to assign that property to the institution at which the research was conducted, the Fondation Leducq will sign an intellectual property agreement (found as a separate exhibit in the Research Agreement) directly with the researcher.